According to the company, the Therakos Cellex photopheresis system is an easy-to-use, integrated system that uses extracorporeal photopheresis, a cellular therapy, to relieve the symptoms of cutaneous T-cell lymphoma (CTCL). The system also has been cleared recently in Canada and Europe.
Michael Yang, general manager of Therakos, said: “The new features of the Therakos Cellex photopheresis system were designed specifically to create a better treatment experience for both patients and the health care professionals administering the therapy. This new system is an example of a medical device and a drug therapy combining in a unique and innovative way to deliver favorable outcomes for patients.”